274 related articles for article (PubMed ID: 30142110)
21. Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: a three-center experience.
Engström AE; Granfeldt H; Seybold-Epting W; Dahm M; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; Koch KT; De Jong M; Lagrand WK; Van Der Sloot JA; Tijssen JG; De Winter RJ; De Mol BA; Piek JJ; Henriques JP
Minerva Cardioangiol; 2013 Oct; 61(5):539-46. PubMed ID: 24096248
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of Impella 5.0 and 5.5 for cardiogenic shock: A single-center 137 patient experience.
Hong Y; Agrawal N; Hess NR; Ziegler LA; Sicke MM; Hickey GW; Ramanan R; Fowler JA; Chu D; Yoon PD; Bonatti JO; Kaczorowski DJ
Artif Organs; 2024 Jul; 48(7):771-780. PubMed ID: 38400638
[TBL] [Abstract][Full Text] [Related]
23. Mechanical circulatory support with the Impella 5.0 and the Impella Left Direct pumps for postcardiotomy cardiogenic shock at La Pitié-Salpêtrière Hospital.
David CH; Quessard A; Mastroianni C; Hekimian G; Amour J; Leprince P; Lebreton G
Eur J Cardiothorac Surg; 2020 Jan; 57(1):183-188. PubMed ID: 31270535
[TBL] [Abstract][Full Text] [Related]
24. Insertion of Impella CP following postcardiotomy cardiogenic shock concomitant with veno-arterial extracorporeal membrane oxygenation.
Iida Y; Tamai K; Oka H; Inaba Y; Miki T; Takahashi H; Hachiya T; Shimizu H
Gen Thorac Cardiovasc Surg; 2021 Jul; 69(7):1144-1146. PubMed ID: 33788168
[TBL] [Abstract][Full Text] [Related]
25. Advantages of intraoperative implantation of Impella 5.5 SmartAssist in the Management of Acute Post-Infarction Ventricular Septal Defect with cardiogenic shock.
Madjarov JM; Katz MG; Madzharov S; Fazal S; Robicsek F
J Cardiothorac Surg; 2021 May; 16(1):132. PubMed ID: 34001192
[TBL] [Abstract][Full Text] [Related]
26. Thirty-five day Impella 5.0 support via right axillary side graft cannulation for acute cardiogenic shock.
Castillo-Sang MA; Prasad SM; Singh J; Ewald GA; Silvestry SC
Innovations (Phila); 2013; 8(4):307-9. PubMed ID: 24145977
[TBL] [Abstract][Full Text] [Related]
27. The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction.
Casassus F; Corre J; Leroux L; Chevalereau P; Fresselinat A; Seguy B; Calderon J; Coste P; Ouattara A; Roques X; Barandon L
J Interv Cardiol; 2015 Feb; 28(1):41-50. PubMed ID: 25689547
[TBL] [Abstract][Full Text] [Related]
28. Microaxial devices for ventricular failure: a multicentre, population-based experience.
Higgins J; Lamarche Y; Kaan A; Stevens LM; Cheung A
Can J Cardiol; 2011; 27(6):725-30. PubMed ID: 21983112
[TBL] [Abstract][Full Text] [Related]
29. Outcome of Impella 2.5 use in patients undergoing Percutaneous Coronary Intervention in Henan, China: a case series.
Bhat RA; Ali SM; Rathi A; Bhat JA; Iqbal RS; Islam MM; Maqbool S; Tibrewal A; Qu Y; Zhang Y; Sun Y; Xiao W; Gao C
Perfusion; 2023 Jan; 38(1):208-213. PubMed ID: 34581607
[TBL] [Abstract][Full Text] [Related]
30. Secular Trend in the Use and Implementation of Impella in High-Risk Percutaneous Coronary Intervention and Cardiogenic Shock: A Real-World Experience.
Hritani AW; Wani AS; Olet S; Lauterbach CJ; Allaqaband SQ; Bajwa T; Jan MF
J Invasive Cardiol; 2019 Sep; 31(9):E265-E270. PubMed ID: 31478893
[TBL] [Abstract][Full Text] [Related]
31. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience.
Engström AE; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; de Jong M; Lagrand WK; van der Sloot JA; Tijssen JG; de Winter RJ; de Mol BA; Piek JJ; Henriques JP
Crit Care Med; 2011 Sep; 39(9):2072-9. PubMed ID: 21602670
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of heart transplantation in patients bridged with Impella 5.0: Comparison with native chest transplanted patients without preoperative mechanical circulatory support.
Monteagudo-Vela M; Panoulas V; García-Saez D; de Robertis F; Stock U; Simon AR
Artif Organs; 2021 Mar; 45(3):254-262. PubMed ID: 32936936
[TBL] [Abstract][Full Text] [Related]
33. Use of the Impella 2.5 system alone, after and in combination with an intra-aortic balloon pump in patients with cardiogenic shock: case description and review of the literature.
Cubeddu RJ; Lago R; Horvath SA; Vignola PA; O'Neill W; Palacios IF
EuroIntervention; 2012 Apr; 7(12):1453-60. PubMed ID: 22522555
[TBL] [Abstract][Full Text] [Related]
34. Preliminary experience with Impella Recover(®) LP5.0 in nine patients with cardiogenic shock: a new circulatory support system in the intensive cardiac care unit.
Bresson D; Sibellas F; Farhat F; Jegaden O; Kirkorian G; Bonnefoy E
Arch Cardiovasc Dis; 2011 Aug; 104(8-9):458-64. PubMed ID: 21944148
[TBL] [Abstract][Full Text] [Related]
35. Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device.
O'Neill WW; Grines C; Schreiber T; Moses J; Maini B; Dixon SR; Ohman EM
Am Heart J; 2018 Aug; 202():33-38. PubMed ID: 29803984
[TBL] [Abstract][Full Text] [Related]
36. Timing of impella placement in PCI for acute myocardial infarction complicated by cardiogenic shock: An updated meta-analysis.
Iannaccone M; Franchin L; Hanson ID; Boccuzzi G; Basir MB; Truesdell AG; O'Neill W
Int J Cardiol; 2022 Sep; 362():47-54. PubMed ID: 35533755
[TBL] [Abstract][Full Text] [Related]
37. Mechanical circulatory support with the Thoratec assist device in patients with postcardiotomy cardiogenic shock.
Körfer R; el-Banayosy A; Posival H; Minami K; Kizner L; Arusoglu L; Körner MM
Ann Thorac Surg; 1996 Jan; 61(1):314-6. PubMed ID: 8561596
[TBL] [Abstract][Full Text] [Related]
38. The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock.
Ogawa S; Suzuki M; Ochi H; Saji M; Mahara K; Takamisawa I; Nishigawa K; Furuichi Y; Takanashi S; Isobe M
Intern Med; 2019 May; 58(10):1459-1462. PubMed ID: 30626823
[TBL] [Abstract][Full Text] [Related]
39. [Initial experience with the Impella left ventricular assist device for postcardiotomy cardiogenic shock and unprotected left coronary artery angioplasty in patients with a low left ventricular ejection fraction].
Bautista-Hernández V; Gutiérrez F; Pinar E; Gimeno JR; Arribas JM; García-Puente J; Ray VG; Arcas R; Valdés M
Rev Esp Cardiol; 2007 Sep; 60(9):984-7. PubMed ID: 17915156
[TBL] [Abstract][Full Text] [Related]
40. Women With Cardiogenic Shock Derive Greater Benefit From Early Mechanical Circulatory Support: An Update From the cVAD Registry.
Joseph SM; Brisco MA; Colvin M; Grady KL; Walsh MN; Cook JL;
J Interv Cardiol; 2016 Jun; 29(3):248-56. PubMed ID: 27229327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
